Company: ZLAB
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001628280-25-008409
Chunk: 63

Company: Zai Lab Ltd
Filing Date: 2025-02-27
Form: 10-K
Item: Item 16
Chunk 63
---
 and development(8)(82)(178)General and administrative(20,275)(16,958)(19,773)Loss from operations(20,283)(17,040)(19,951)Interest income28,176 30,840 12,857 Other (expense) income, net(5,438)4,029 (8,678)Profit (Loss) before income tax and equity in loss of subsidiaries2,455 17,829 (15,772)Equity in loss of subsidiaries(259,558)(352,449)(427,514)Income tax expense— — — Net loss(257,103)(334,620)(443,286)Other comprehensive income (loss), net of tax of nil:Foreign currency translation adjustment12,889 11,941 49,330 Comprehensive loss(244,214)(322,679)(393,956)

F-40

Schedule I — Condensed Financial Information of RegistrantZai Lab Limited Financial Information of Parent Company Condensed Statements of Cash Flows(in thousands of $)Year Ended December 31,202420232022Cash flows from operating activities:Net loss(257,103)(334,620)(443,286)Adjustments to reconcile net loss to net cash provided by (used in) operating activities:Amortization of deferred income— — (234)Share based compensation4,759 3,217 3,724 Equity in loss of subsidiaries259,558 352,449 427,514 Loss from fair value changes of equity investment of readily determinable fair value6,105 (2,789)8,952 Changes in operating assets and liabilities:Prepayments and other current assets2,266 2,780 (7,839)Other current liabilities(248)(379)1,648 Net cash provided by (used in) operating activities15,337 20,658 (9,521)Cash flows from investing activities:Purchases of short-term investments(330,000)— (260,274)Proceeds from maturity of short-term investments— — 705,274 Investment in subsidiaries(271,830)(392,893)(80,942)Net cash (used in) provided by investing activities(601,830)(392,893)364,058 Cash flows from financing activities:Proceeds from exercises of stock options3,200 2,369 5,870 Proceeds